Civica Rx, Vizient team up to cut drug shortages

Civica Rx, the hospital-owned generic drug company, is collaborating with Vizient to help reduce drug shortages.

Under the agreement, using analytics and data capabilities, Vizient will provide Civica insights into purchasing patterns and provider needs to help the hospital-owned drug company anticipate gaps in drug availability and affordability.

"We applaud Vizient for helping to find innovative ways to reduce drug shortages through their analytics and data expertise," said Martin VanTrieste, Civica president and CEO. "The more people collaborating to solve the nation’s drug shortage problem the better. We thank Vizient for prioritizing hospital patients by taking action to help them have timely access to the treatments they desperately need."

Vizient is a healthcare improvement company that provides expertise, analytics and advisory services to providers.

More articles on pharmacy:
Lupin recalls 18,408 bottles of antibiotic in US
Bluebird Bio prices gene therapy at $1.8M
10 hospitals seeking pharmacy leaders

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Content

Featured Webinars

Featured Whitepapers